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Long-term heavy alcohol consumption could result in a range of health, social, and behavioral problems. People who abuse alcohol
are at high risks of seriously having osteopenia, periodontal disease, and compromised oral health. However, the role of ethanol
(EtOH) in the biological functions of human dental pulp cells (DPCs) is unknown. Whether EtOH affects the odontoblastic
differentiation of DPCs through the mechanistic target of rapamycin (mTOR) remains unexplored. The objective of this study
was to investigate the effects of EtOH on DPC differentiation and mineralization. DPCs were isolated and purified from human
dental pulps. The proliferation and odontoblastic differentiation of DPCs treated with EtOH were subsequently investigated.
Different doses of EtOH were shown to be cytocompatible with DPCs. EtOH significantly activated the mTOR pathway in a
dose-dependent manner. In addition, EtOH downregulated the alkaline phosphatase activity, attenuated the mineralized nodule
formation, and suppressed the expression of odontoblastic markers including ALP, DSPP, DMP-1, Runx2, and OCN. Moreover,
the pretreatment with rapamycin, a specific mTOR inhibitor, markedly reversed the EtOH-induced odontoblastic differentiation
and cell mineralization. Our findings show for the first time that EtOH can suppress DPC differentiation and mineralization in
a mTOR-dependent manner, indicating that EtOH may be involved in negatively regulating the dental pulp repair.
1. Introduction
Alcohol is widely consumed throughout the world and has
attracted human concernment for thousands of years. Alco-
hol abuse can place the health of an individual at risk for a
series of diseases. According to the World Health Organiza-
tion, heavy alcohol consumptions are associated with many
chronic diseases, including low bone mass, hepatitis, and car-
diovascular diseases [1]. Chronic and heavy alcohol con-
sumption is known to result in bone loss, decreased bone
formation, increased risks for bone fracture, and delayed
fracture healing [2–4]. Moderate alcohol consumption may
actually have a modest favorable effect on bone density, par-
ticularly in postmenopausal women, although not all studies
agree [5–8]. However, alcohol intake of three or more drinks
per day is detrimental to bone health [9]. Recent experimen-
tal evidences indicated that the mammalian target of rapa-
mycin (mTOR) signal may contribute to the maintenance
of bone homeostasis and the differentiation of mesenchymal
stem cells [10, 11].
DPCs possess multipotent differentiation potential and
the ability to form dentin-pulp-like complexes throughout
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life. When the dental pulp is confronted with trauma,
microbes, or chemicals, a host of inflammatory cytokines
are released [12]. These insults can stimulate the underlying
progenitor pulp cells to differentiate into odontoblasts [13],
which are capable of secreting dentin matrix proteins as part
of the reparative dentinogenesis [14]. Odontoblasts secrete
several collagenous and noncollagenous proteins, such as
type I collagen, osteopontin, dentin matrix protein 1
(DMP1), and dentin sialophosphoprotein (DSPP), which
are special biological markers for the odontoblast/osteo-
blast-like differentiation of DPCs [15, 16]. Studies have
shown that a variety of signal pathways participate in the reg-
ulation of dental pulp cell differentiation, such as BMP, Wnt,
and Notch signaling [17–19]. However, the impact of alcohol
on odontoblastic differentiation of human dental pulp cells
(DPCs) remains unclear.
Therefore, the objective of the present study was to
investigate the effects of ethanol (EtOH) on the prolifera-
tion and odontoblastic differentiation of DPCs. The role
of mTOR signaling in EtOH-mediated odontoblastic differ-
entiation was also investigated. The results of this study will
shed light on the role of alcohol consumption on the health
of human dental pulp cells and their ability in tissue repair
and regeneration.
2. Materials and Methods
2.1. Cell Cultures. DPCs were isolated and characterized as
described previously [20, 21]. Dental pulp tissues were
obtained from explants of clinically healthy dental pulps
from human adult third molars that were removed from
individuals undergoing tooth extraction for orthodontic
treatment. The procedure was approved by the Institutional
Review Board of the University of Maryland Baltimore. The
pulp tissue was digested in a solution of 3mg/mL collage-
nase type I (Worthington Biochem, Freehold, NJ, USA)
and 4mg/mL dispase (Boehringer Mannheim, Indianapo-
lis, IN, USA) for 1 h at 37°C. In the present study, DPCs
were cultured in alpha modified Eagle’s medium (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% foetal calf
serum (FCS; Invitrogen), 10mM L-ascorbic acid 2-
phosphate (AA), 2mM L-glutamate, 100 units/mL penicillin,
and 100μg/mL streptomycin at 37°C in a humidified atmo-
sphere of 5% CO2 and 95% air. When the cells reached 80%
confluence, they were harvested using trypsin/ethylene
diamine tetraacetic acid (EDTA) (Gibco, Carlsbad, CA,
USA) and subcultured at a ratio of 1 : 3. The 4th passage
DPCs were used in the following experiments.
2.2. Cell Viability. DPCs were seeded in 24-well plates at a
density of 3× 104 cells/well. Cells were stained by live/dead
viability assay kit (Life Technologies) after culture for 1, 7,
and 14 d as described previously [22]. Cells were washed with
PBS, followed by incubation with the dye. Live cells were
stained green with 2mM calcein AM and dead cells were
marked red with 4mM ethidium homodimer-1, and they
were examined using epifluorescence microscopy (Eclipse
TE2000-S, Nikon, Melville, NY). The percentage of live cells
and the live cell density were calculated as previously
described [21]. Three random sections were analyzed for
each sample.
2.3. Cell Proliferation Assays. A cell counting kit (CCK-8,
Dojindo, Tokyo, Japan) was used to evaluate cell prolifera-
tion at 1, 3, 5, and 7 d. Four replicates in each group were
used for this assay. CCK-8 is based on the WST-8 reaction
that produces an orange formazan dye in an amount that is
directly related with the number of viable cells. The cell
proliferative rate was determined via the absorbance at an
optical density of 450nm (OD450nm) using a microplate
reader (SpectraMax M5, Molecular Devices, Sunnyvale,
CA) according to the manufacturer’s protocol.
2.4. Western Blot Analysis. Cells were harvested and lysed in
lysis buffer: 20mmol/L Na2PO4 at pH 7.4, 150mmol/L NaCl,
1% Triton X-100, 1% aprotinin, 1mmol/L phenymethysulfo-
nyl fluoride, 10mg/mL leupeptin, 100mmol/L NaF, and
2mmol/L Na3VO4. Lysates were centrifuged at 12,000 rpm
for 15min. The supernatant was collected, and the protein
content was determined using the Bio-Rad protein assay.
SDS-PAGE sample buffer (10mM Tris-HCl, pH 6.8, 2%
SDS, 10% glycerol, and 0.2M DTT) was added to the lysates.
Lysates were heated to 100°C for 8min, and 20μg of the total
protein was loaded in each well of a 10% SDS-PAGE gel.
Western blot analysis was performed as reported previously
[23, 24]. The following primary antibodies were used:
phospho-mTOR (p-mTOR), and total mTOR antibody (Cell
Signaling Technology, Beverly, MA, USA).
2.5. Alkaline Phosphatase Activity. DPCs were preincubated
with 50mM rapamycin 1 hour and then exposed to 50mM
EtOH; this procedure was repeated at day 3. After the treat-
ment, the cells were scraped into cold PBS and then sonicated
in an ice bath and centrifuged at 1500×g for 5min. Then, the
ALP activity was measured in the supernatant using ALP
assay mixtures containing 0.1M diethanolamine, 1mM
MgCl2, and 10mg/mL p-nitrophenyl phosphate. After incu-
bation at 37°C for 30min, the reaction was stopped by the
addition of NaOH, and the absorbance was measured at
410 nm using the microplate reader (SpectraMax M5).
2.6. Reverse Transcriptase PCR (RT-PCR) and Real-Time
Quantitative PCR (qPCR). The expression levels of ALP,
DSPP, DMP-1, Runx2, and OCN mRNA were determined
by SYBR green real-time reverse transcription-PCR (RT-
PCR) as described previously [25]. Total RNA were extracted
using TRIzol reagent. Quantitative determination of RNA
levels were performed in triplicate in three independent
experiments. Real-time PCR and data collection were per-
formed with an ABI PRISM 7500 sequence detection system.
The housekeeping gene GAPDHwas used as an internal con-
trol to normalize the expression levels of different genes. For
each primer set, the melting curves were performed to ensure
that a single peak was produced. The data for gene expression
were analyzed with the△△Ct method. The primers used for
the amplification of the indicated genes are listed in Table 1.
2.7. Von Kossa Staining. Specific calcifications were detected
by von Kossa staining [26, 27]. Briefly, DPCs were plated in
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six-well plates at a density of 1× 105 cells per well and cul-
tured in DMEM supplemented with 10% FBS, 50mg/mL
ascorbic acid, 10mmol/L sodium β-glycerophosphate, and
10nmol/L dexamethasone. DPCs were then pretreated with
50mM rapamycin for 1 hour prior to the addition of
50mM EtOH. This treatment was repeated every 3 d. After
14 d of treatment, the cells were treated with a 5% silver
nitrate solution and exposed to ultraviolet light for 30min.
This solution was then neutralized with 5% sodium thio-
sulfate for 2min, and the cells were rinsed with distilled
water for 5min. Finally, the cells were stained with nuclear
fast red (Sigma, Deisenhofen, Germany) for 1min. To
quantify the mineralization, the calcium content was mea-
sured by a quantitative colorimetric method using a cal-
cium assay kit following the manufacturer’s instructions.
The calcium content of the cell layer was determined at
Table 1: List of reverse transcriptase polymerase chain reaction primers.
Gene Forward Reverse
ALP CTATCCTGGCTCCGTGCTC GCTGGCAGTGGTCAGATGTT
DSPP TGGAGCCACAAACAGAAGCAA TCCAGCTACTTGAGGTCCATC
DMP-1 GTGAGTGAGTCCAGGGGAGATAA TTTTGAGTGGGAGAGTGTGTGC
Runx2 GACTGTGGTTACCGTCATGGC ACTTGGTTTTTCATAACAGCGGA
OCN CTCACACTCCTCGCCCTATT TTGGACACAAAGGCTGCAC
GAPDH TCAACGACCCCTTCATTGAC ATGCAGGGATGATGTTCTGG
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Figure 1: DPCs phenotype via flow cytometry. The expression of a series of cell surface markers associated with the mesenchymal stem cell
(MSC) phenotype was investigated using flow cytometry. Analysis of molecular surface antigen markers in DPCs by flow cytometry indicated
that the cells were negative for CD34, whereas they were positive for CD73, CD90, and CD105.
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day 14 of odontogenic culture. The absorbance of the
solutions was read at 570 nm using a UV-visible light
spectrophotometer.
2.8. Statistical Analysis. All experiments were repeated at
least three times. Data are expressed as mean± standard devi-
ation (SD). Results of at least three independent experiments
(always performed with cells isolated from different donors)
were compared by one-way ANOVA. Differences between
groups were evaluated with Tukey’s posttest. p values < 0.05
were considered significant.
3. Results
3.1. Identification of Stem Cell Phenotypic Markers in Primary
DPCs. The surface markers of DPCs were analyzed using
flow cytometry. Consistent with other mesenchymal stem cell
populations (Figure 1), themajority ofDPCs exhibited intense
expression of mesenchymal surface molecular markers
(CD73—99.2%, CD90—99.6%, and CD105—99.3%). On the
other hand, DPCs exhibited weak expression of surface
markers (CD34—0.2%), indicating that the DPCs contained
mesenchymal progenitors.
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Figure 2: Effect of EtOH on cell viability and proliferation of DPCs. (a) Representative live/dead images of EtOH-treated DPCs after days 1, 7,
and 14 of culture. Live cells were stained in green and dead cells were stained in red. In all four groups, live cells were abundant, and dead cells
were few (scale bar = 50μm). (b) Percentage of live cells of DPCs was around 90%. Data represent mean± SD of 3 experiments with triplicates.
(c) EtOH increased the cell proliferation. Data represent mean± SD of 3 experiments with triplicates. ∗p < 0 05 versus control group.
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3.2. DPC Viability and Cell Proliferation. In order to evaluate
the effects of EtOH treatment on DPC cytocompatibility,
cellular viability was assessed using live/dead staining after
24 hours of culture. Representative live/dead staining images
are shown in Figure 2(a). There were numerous live cells
(stained green) and a few dead cells (stained red). In
Figure 2(b), the percentages of live cells in all four groups
were approximately 90% and were not significantly different
among the three doses of EtOH (p > 0 1). Cell number signif-
icantly increased from day 1 to day 14, most likely due to cell
proliferation (Figure 2(c)). The concentrations of EtOH of up
to 50mM enhanced cell proliferation compared to the
untreated DPCs (Figure 2(d)). Overall, these results demon-
strate that 50mM EtOH, used in the other experiments of
the present study, was not cytotoxic to DPCs.
3.3. mTOR Activation in Response to EtOH in DPCs. To
determine whether the mTOR signaling pathway is involved
in the EtOH-mediated differentiation of DPCs, DPCs were
treated with EtOH for 24 hours. EtOH treatment elevated
the expression levels of phospho-mTOR signaling with
increasing doses, compared to the control group, as shown
in Figure 3(a). The small molecule rapamycin has been
widely used as a selective mTOR inhibitor [28]. We used
rapamycin to prevent mTOR phosphorylation in response
to EtOH. As depicted in Figure 3(b), EtOH-induced
phospho-mTOR was downregulated following pretreatment
with 50mM rapamycin. These results confirmed that in
DPCs EtOH triggers the activation of the mTOR pathway
as confirmed by the inhibitory action of rapamycin.
3.4. EtOH-Induced mTOR Activation Increases Alkaline
Phosphatase Activity, Alkaline Phosphatase mRNA
Expression, andMineralization.TounderstandwhetherEtOH
affects the odontogenic differentiation of DPCs, an ALP activ-
ity assaywas performed. To this end,ALPactivity significantly
decreased in the EtOH-treated group until day 14, compared
to the control group (Figure 4(a)). The decreased ALP activity
EtOH (mM) 0 10 20 50
p-mTOR
mTOR
0 10 20 50
0
1
2
3
Ra
tio
s o
f s
ca
n 
va
lu
e
⁎
⁎
⁎
EtOH (mM)
(a)
Ra
tio
s o
f s
ca
n 
va
lu
e 
0
C
on
tro
l
Ra
pa
m
yc
in
Et
O
H
Et
O
H
 +
 ra
pa
m
yc
in
1
2
3
⁎
⁎⁎
EtOH (‒) EtOH (+)
Rapamycin
p-mTOR
mTOR
‒ + ‒ +
(b)
Figure 3: EtOH upregulates mTOR phosphorylation in DPCs in a dose-dependent manner. (a) DPCs were treated with different
concentrations of EtOH for 24 hours. Lower panels show the ratios of band densities of phosphor-mTOR to mTOR. (b) Confluent DPCs
cells were preincubated with the mTOR inhibitor rapamycin (50mM) for 1 hour before treatment with EtOH. Rapamycin decreases
EtOH-induced mTOR phosphorylation. Data represent mean± SD of 3 experiments with triplicates. ∗p < 0 05 versus control group.
∗∗p < 0 05 versus EtOH group.
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was significantly enhanced following pretreatment with
rapamycin. The results of the ALP mRNA expression were
consistent with ALP assay (Figure 4(b)). Next, we investigated
themineralized nodule formation, an index of terminal odon-
toblastic differentiation, in DPCs after 14 d of incubation with
EtOH in the absence or presence of rapamycin. Treatment of
DPCswith EtOHdecreased themineralizednodule formation
and calcium content. Conversely, an increase in calcified nod-
ule formation (Figure 4(c)) and calcium content (Figure 4(d))
was observed in cells treated with EtOH in the presence of
rapamycin. These results suggest that the downstream effects
of EtOHon the odontoblasticmaturation ofDPCsweremedi-
ated through the activation of the mTOR signaling pathway.
3.5. EtOH Triggers DPC Odontoblastic Differentiation in an
mTOR-Dependent Manner. To further investigate the effects
of EtOH on odontoblastic differentiation of DPCs, cells were
exposed to EtOH for 1, 7, and 14 d. EtOH markedly down-
regulated the mRNA expression of critical odontoblastic
genes including DSPP, DMP-1, Runx2, and OCN mRNA.
In contrast, expression of these genes was significantly ele-
vated by the addition of rapamycin prior to EtOH treatment
(Figure 5). These results further indicate that mTOR is a key
mediating factor controlling EtOH-induced odontoblastic
differentiation of DPCs.
4. Discussion
The long-term detrimental effects of alcoholism on bone
mass have been relatively well established [29]. Previous
studies showed that heavy chronic alcohol consumption is
associated with a variety of risk factors that may contribute
to the pathogenesis of bone disease, including malabsorption,
hypogonadism, poor nutrition, vitamin D deficiency, liver
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Figure 4: Effect of EtOH-induced ALP activity and mineralized nodule formation in DPCs. (a, b) DPCs were treated with EtOH (50mM) in
the absence or presence of rapamycin (50mM, pretreatment for 1 h). Cells were retreated every 3 days. ALP activity (a) and ALP mRNA
expression (b) were measured at each time point. (c) DPCs were cultured in osteogenic induction medium for 14 days, and the
mineralized nodule formation was assessed by von Kossa staining (scale bar = 100μm). (d) On 14 days, the calcium content was
determined. Data represent mean± SD of 3 experiments with triplicates. ∗p < 0 05 versus control group. ∗∗p < 0 05 versus EtOH group.
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disease, and parathyroid dysfunction [30]. The effect of
alcohol on cell proliferation has been reported for various
types of cells [31–33]. Our observations in the present
study indicate that alcohol treatment was able to increase
the proliferation rate of DPCs. Furthermore, The concen-
trations of EtOH of up to 50mM was found to not alter
the viability of DPCs. Liu et al. reported that treatment
of marrow mesenchymal stem cells with alcohol led to
an increase in cell proliferation as determined by the
methylthiazolyldiphenyl-tetrazolium bromide assay [34].
The effect of EtOH on the proliferation of DPCs is also
consistent with that reported for mouse bone marrow
mesenchymal stem cells.
Alcohol has been reported to activate mTOR in bone
marrow mesenchymal cells [34]. Interestingly, this study
showed that the addition of rapamycin, a widely used mTOR
inhibitor [35], attenuated the alcohol-induced responses.
These results suggested that alcohol decreased the differen-
tiation and mineralization of osteoblast-like cells via the
activation of mTOR signaling. To investigate whether
mTOR signaling pathway is involved in EtOH-induced
odontogenic differentiation of DPCs, we assessed the acti-
vation of mTOR signaling in EtOH-treated DPCs under
conditions designed to induce odontoblastic differentiation
and its role in odontoblastic differentiation with the use of
mTOR inhibitors. Among the concentration gradients in
our experiment, we found that 50mM EtOH significantly
upregulated phospho-mTOR activity in DPCs. Thus, this
concentration was selected for subsequent experiments in
the present study. Rapamycin was also used to test the effect
of alcohol on mTOR phosphorylation. The phosphorylation
of mTOR was partially inhibited by rapamycin. The mecha-
nism of how EtOH regulates the odontoblast differentiation
of DPCs is complicated and has not yet been elucidated
completely. In addition, whether mTOR signaling partici-
pates in odontoblast differentiation of DPCs has not yet been
elucidated completely.
DPCs from dental pulp tissues represent a population of
mesenchymal stem/progenitor cells. The high proliferative
potential of DPCs makes this population of cells suitable
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Figure 5: Effects of EtOH treatment on the odontoblastic differentiation of DPCs. DPCs cells were pre-incubated with rapamycin (50mM)
for 1 hour before treatment with EtOH. The mRNA expression of DSPP, DMP-1, Runx2, and OCN was analyzed using real-time RT-PCR.
Data represent mean± SD of 3 experiments with triplicates. ∗p < 0 05 versus control group. ∗∗p < 0 05 versus EtOH group.
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for cell-based regeneration and especially for dentin repair.
DPCs could form the dentin-like tissues and bone-like tissues
in vivo [36]. Several studies have showed that dentin-like tis-
sue formation is associated with DPCs [37–39]. ALP activ-
ity is most often used as an early marker of odontoblastic
differentiation and plays an important role in dentin-like
tissue formation. In the present study, greater ALP activity
and ALP mRNA were achieved when the mTOR signaling
pathway was inhibited by rapamycin. Consistent with this
finding, more mineralized nodules were also observed in
DPCs treated with rapamycin at the late stage of odontoblas-
tic differentiation. These results indicate that the mTOR sig-
naling pathway is partly controlling the effects of EtOH on
the odontoblastic differentiation of DPCs.
Furthermore, the gene expression levels of the related
odontoblastic markers such as DSPP, DMP-1, Runx2, and
OCN were measured to investigate the effects of mTOR sig-
naling on the differentiation ability of odontoblasts in vitro.
Runx2, of the runt domain gene family, is an essential
transcription factor that controls bone and tooth develop-
ment by regulating osteoblast and odontoblast differentia-
tion [40, 41]. DSPP and DMP-1 are members of the small
integrin-binding ligand N-linked glycoprotein (SIBLING)
family. DSPP was originally considered to be dentin-
specific. Although several studies have recently shown its
expression in bone [42–44], DSPP remains a major marker
of odontoblastic differentiation. In addition, DMP-1 is essen-
tial for the mineralization of bone and dentin [45, 46]. Fur-
thermore, OCN can be expressed by odontoblasts and is
present in the dentin matrix, and it is also thought to be a
reparative molecule within the dental pulp [47]. In the
present study, DSPP, DMP-1, Runx2, and OCN mRNA
levels were downregulated in the EtOH-treated DPCs.
However, rapamycin significantly reversed the EtOH-
induced downregulation of DSPP, DMP-1, Runx2, and
OCN mRNAs. This provided further evidence that the
mTOR signaling pathway plays an important role in EtOH-
mediated DPC odontoblastic differentiation. Our study pro-
vides a basis that high doses of alcohol may be detrimental
to DPCs’ repair and regenerative capability.
However, the level of odontogenic differentiation of
DPCs can be regulated also by other important factors.
Paduano et al. demonstrated that hydrogel scaffolds
derived from bone extracellular matrix (bECM) promoted
odontogenic differentiation of dental pulp stem cells in
the absence of external inducers, and these scaffolds could
be combined with osteo/odontogenic medium or growth
factors [48]. Qu and Liu demonstrated that gelatin/bioactive
glass hybrid scaffolds provided an excellent environment for
dental pulp stem cells for odontogenic differentiation [49].
Moreover, dental-derived mesenchymal stem cells exhibited
a predisposition toward other phenotypes when cultured
in the appropriate media [50–53]. Interestingly, the poli-
phenolic fractions isolated from the beer brewing process
enhanced the antioxidant and antitumor activity. Further
study is needed to determine whether the positive bioac-
tive compounds of beer and other agents could regulate
the odontogenic differentiation of DPCs and their under-
lying mechanisms.
In conclusion, the present study demonstrated for the
first time that EtOH can downregulate the odontoblastic
differentiation of DPCs through activation of the mTOR sig-
naling pathway, suggesting that EtOH plays an important
role during the odontoblastic differentiation. Regenerating
dentin is an important target for the treatment of dental pulp
exposure [54]. The primary objective of vital pulp therapy is
to maintain the health of pulp tissues and to stimulate the
remaining pulp to regenerate the dentin-pulp complex [55].
Therefore, the aim of the present study was to investigate
the potential effect of heavy EtOH consumption on pulp
therapy as a factor that needs to be considered in clinical
practice. Further research is needed to fully understand and
support the clinical indications suggesting that heavy alco-
holic consumption should be discouraged during vital pulp
therapy in adults.
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